Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-Ox40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity

Cell Reports - United States
doi 10.1016/j.celrep.2019.05.027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Anti-Tumor Efficacy and Biomarker Evaluation of Agonistic Anti-Ox40 Antibodies in Preclinical Models

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Anti-Tumor Activity of Stability-Engineered IgG-like Bispecific Antibodies Targeting TRAIL-R2 and LTβR

mAbs
AllergyImmunology
2009English

Anti-Oxidant Capacity and Anti-Tumor T Cell Function: A Direct Correlation

OncoImmunology
OncologyAllergyImmunology
2015English

Anti-Ccr7 Therapy Exerts a Potent Anti-Tumor Activity in a Xenograft Model of Human Mantle Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

MORAb-202, an Antibody Drug Conjugate Utilizing Humanized Anti-Human FRa Farletuzumab and the Microtubule-Targeting Agent Eribulin, Has Potent Anti-Tumor Activity

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2015English

FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy